NeoGenomics Inc. Common Stock vs Constellation Brands Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Constellation Brands Inc. Common Stock trades at $127.6 (market cap $21.50B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 10× NeoGenomics Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.24% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NEO | STZ | |
|---|---|---|
Market Cap | $2.14B | $21.50B |
Volume | 2,228,400 | 2,104,680 |
Sector | Health | Consumer Staples |
52-Week High | $19.91 | $166.68 |
52-Week Low | $7.19 | $112.77 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $2.44B | $31.72B |
Dividend Yield | — | 3.24% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →